By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Synta Pharmaceuticals 

45 Hartwell Avenue

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-274-8200 Fax: 781-274-8228



Company News
Synta Pharmaceuticals (SNTA) Announces Advancement Of Ganetespib Into Phase 3 Extension Of AML LI-1 Study For Patients With AML And High-Risk MDS 7/22/2014 10:15:31 AM
Synta Pharmaceuticals (SNTA) To Present At The 9th Annual JMP Securities Healthcare Conference 6/20/2014 7:24:12 AM
Synta Pharmaceuticals (SNTA) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 7:48:02 AM
Synta Pharmaceuticals (SNTA) Announces Presentations At The 2014 American Society of Clinical Oncology (ASCO) Annual Meeting 5/28/2014 7:34:31 AM
Synta Pharmaceuticals (SNTA) Reports First Quarter 2014 Financial Results and Provides Corporate Update 5/8/2014 9:20:08 AM
Synta Pharmaceuticals (SNTA) Announces Results From Final Analysis Of The GALAXY-1 Trial Of Ganetespib In NSCLC 5/8/2014 7:52:46 AM
Synta Pharmaceuticals (SNTA) To Host Conference Call And Webcast Of First Quarter 2014 Financial Results On May 8, 2013 4/30/2014 8:12:44 AM
Synta Pharmaceuticals (SNTA) Enters Into Agreement To Sell $5.0 Million In Common Stock Directly To An Affiliate Of Synta Board Member Bruce Kovner 4/14/2014 9:35:18 AM
Synta Pharmaceuticals (SNTA) Announces Positive Interim Results From The ENCHANT-1 Trial Of Ganetespib In Metastatic Breast Cancer At The 9th European Breast Cancer Conference 3/20/2014 10:22:17 AM
Synta Pharmaceuticals (SNTA) Reports Fourth Quarter And Year-End 2013 Financial Results And Provides Corporate Update 3/11/2014 7:01:50 AM